A detailed history of Lmr Partners LLP transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Lmr Partners LLP holds 31,177 shares of ITCI stock, worth $3.96 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
31,177
Previous 33,289 6.34%
Holding current value
$3.96 Million
Previous $2.28 Million -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$67.99 - $80.84 $143,594 - $170,734
-2,112 Reduced 6.34%
31,177 $2.28 Million
Q2 2024

Aug 14, 2024

BUY
$64.76 - $79.84 $798,426 - $984,347
12,329 Added 58.82%
33,289 $2.28 Million
Q1 2024

May 15, 2024

BUY
$64.37 - $75.65 $1.35 Million - $1.59 Million
20,960 New
20,960 $1.45 Million
Q3 2023

Nov 14, 2023

BUY
$52.09 - $64.1 $244,823 - $301,270
4,700 New
4,700 $244,000
Q2 2022

Aug 15, 2022

SELL
$43.0 - $65.64 $322,500 - $492,300
-7,500 Reduced 48.7%
7,900 $451,000
Q1 2022

May 16, 2022

BUY
$38.74 - $62.09 $596,596 - $956,186
15,400 New
15,400 $942,000
Q4 2021

Feb 14, 2022

SELL
$35.2 - $53.42 $422,400 - $641,040
-12,000 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$28.72 - $42.49 $344,640 - $509,880
12,000 New
12,000 $447,000
Q2 2020

Aug 14, 2020

SELL
$14.35 - $26.64 $717,500 - $1.33 Million
-50,000 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$12.31 - $33.12 $615,500 - $1.66 Million
-50,000 Reduced 50.0%
50,000 $791,000
Q4 2019

Feb 14, 2020

BUY
$7.26 - $38.49 $726,000 - $3.85 Million
100,000 New
100,000 $3.43 Million

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $12B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.